Impact of high- versus low-dose neuromuscular blocking agent administration on unplanned 30-day readmission rates in retroperitoneal laparoscopic surgery

Martijn Boon, Chris Martini, H Keri Yang, Shuvayu S Sen, Rob Bevers, Michiel Warlé, Leon Aarts, Marieke Niesters, Albert Dahan, Martijn Boon, Chris Martini, H Keri Yang, Shuvayu S Sen, Rob Bevers, Michiel Warlé, Leon Aarts, Marieke Niesters, Albert Dahan

Abstract

Recent data shows that a neuromuscular block (NMB) induced by administration of high doses of rocuronium improves surgical conditions in certain procedures. However, there are limited data on the effect such practices on postoperative outcomes. We performed a retrospective analysis to compare unplanned 30-day readmissions in patients that received high-dose versus low-dose rocuronium administration during general anesthesia for laparoscopic retroperitoneal surgery. This retrospective cohort study was performed in the Netherlands in an academic hospital where routine high-dose rocuronium NMB has been practiced since July 2015. Charts of patients receiving anesthesia between January 2014 and December 2016 were searched for surgical cases receiving high-dose rocuronium and matched with respect to procedure, age, sex and ASA classification to patients receiving low-dose rocuronium. The primary post-operative outcome was unplanned 30-day readmission rate. There were 130 patients in each cohort. Patients in the high- and low-dose rocuronium cohorts received 217 ± 49 versus 37 ± 5 mg rocuronium, respectively. In the high-dose rocuronium group neuromuscular activity was consistently monitored; matched patients were unreliably monitored. All patients receiving high-dose rocuronium were reversed with sugammadex, while just 33% of matched patients were reversed with sugammadex and 20% with neostigmine; the remaining patients were not reversed. Unplanned 30-day readmission rate was significantly lower in the high-dose compared to the low-dose rocuronium cohort (3.8% vs. 12.7%; p = 0.03; odds ratio = 0.33, 95% C.I. 0.12-0.95). This small retrospective study demonstrates a lower incidence of unplanned readmissions within 30-days following laparoscopic retroperitoneal surgery with high-dose relaxant anesthesia and sugammadex reversal in comparison to low-dose relaxant anesthesia. Further prospective studies are needed in larger samples to corroborate our findings and additionally assess the pharmacoeconomics of high-dose relaxant anesthesia taking into account the benefits (reduced readmissions) and harm (cost of relaxants and reversal agents) of such practice.

Conflict of interest statement

Martijn Boon, Chris Martini, Michel Warle and Albert Dahan received speaker and/or consultancy fees from MSD Bv; Kery Yang and Shuvaya Sen are employees of Merck & Co; Rob Bevers, Leon Aarts and Marieke Niesters have no conflicts to report. The commercial affiliation does not alter our adherence to PLOS ONE policies on sharing data and materials.

References

    1. Barash PG, Cullen BC, Stoelting RK, Cahalan MK, Stock MC, Ortega R, et al. Clin Anesth, 8th edition Wolters Kluwer, Philadelphia, 2017.
    1. King M, Sujirattanawimol N, Danielson DR, Hall BA, Schroeder DR, Warner DO. Requirements for muscle relaxants during radical retropubic prostatectomy. Anesthesiology. 2000;93:1392–1397.
    1. Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth. 2014;112:498–505. doi:
    1. Torensma B, Martini CH, Boon M, Olofsen E, in ‘t Veld B, Liem L, et al. Deep Neuromuscular Block Improves Surgical Conditions during Bariatric Surgery and Reduces Postoperative Pain: A Randomized Double Blind Controlled Trial. PloS One. 2016;11:e0167907 doi:
    1. Kim HJ, Lee K, Park WK, Lee BR, Joo HM, Koh YW, et al. Deep neuromuscular block improves the surgical conditions for laryngeal microsurgery. Br J Anaesth. 2015;115(6):867–72. doi: .
    1. Kim MH, Lee KY, Lee KY, Min BS, Yoo YC. Maintaining optimal surgical conditions with low insufflation pressures is possible with deep neuromuscular blockade during laparoscopic colorectal surgery: a prospective, randomized, double-blind, parallel-group clinical trial. Medicine (Baltimore). 2016;95:e2920 doi:
    1. Koo BW, Oh AY, Seo KS, Han JW, Han HS, Yoon YS. Randomized clinical trial of moderate versus deep neuromuscular block for low-pressure pneumoperitoneum during laparoscopic cholecystectomy. World J Surg. 2016;40:2898–2903. doi:
    1. Staehr-Rye AK, Rasmussen LS, Rosenberg J, Juul P, Lindekaer AL, Riber C, et al. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesth Analg. 2014;119:1084–1092. doi:
    1. Yoo YC, Kim NY, Shin S, Choi YD, Hong JH, Kim CY, et al. The intraocular pressure under deep versus moderate neuromuscular blockade during low-pressure robot assisted laparoscopic radical prostatectomy in a randomized trial. PLoS One. 2015;10:e0135412 doi:
    1. Blobner M, Frick CG, Stauble RB, Feussner H, Schaller SJ, Unterbuchner C, et al. Neuromuscular blockade improves surgical conditions (NISCO). Surgical endoscopy. 2015;29(3):627–36. Epub 2014/08/16. doi: .
    1. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skoygaard LT, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997;41:1095–1103.
    1. Grosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ. 2012;345:e6329 doi:
    1. Boon M, Martini C, Broens S, van Rijnsoever E, van der Zwan T, Aarts L, et al. Improved postoperative oxygenation after antagonism of moderate neuromuscular block with sugammadex versus neostigmine after extubation in 'blinded' conditions. Br J Anaesth. 2016;117:410–411. doi:
    1. Groudine SB, Soto R, Lien C, Drover D, Roberts K. A randomized, dose-finding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg. 2007;104:555–562. doi:
    1. Kopman AF, Naguib M. Is deep neuromuscular block beneficial in laparoscopic surgery? No, probably not. Acta Anaesthesiol Scand. 2016;60:717–722. doi:
    1. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare Fee-for-Service Program. N Engl J Med. 2009;360:1418–1428. doi:
    1. Wilbur MAB, Mannschreck DB, Angarita AM, Matsuno RK, Tanner EJ, Stone RL, et al. Unplanned 30-day hospital readmission as quality measure in gynecological oncology. Gynecol Oncol. 2016;143:604–610. doi:
    1. Lee MS, Venkatesh KK, Growdon WB, Ecker JL, York-Best CM. Predictors of 30-day readmission following hysterectomy for benign and malignant indications at a tertiary care academic medical center. Am J Obstet Gynecol. 2016;214:607.e1–607.e12. doi:
    1. Clark RM, Lee MS, Rauh-Hain JA, Hall T, Boruta DM, del Carmen MG, et al. Surgical Apgar score and prediction of morbidity in women undergoing hysterectomy for malignancy. Gynecol Oncol. 2015;136:516–520. doi:
    1. Clark RM, Growdon WB, Wichert A, Boruta D, del Carmen MG, Goodman AK, et al. Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma. Gynecol Oncol. 2013;130:407–410. doi:
    1. Keller DS, Khorgami Z, Sendseid B, Khan S, Delaney CP. Identifying causes for high readmission rates after stoma reversal. Surg Endosc. 2014;28:2163–1268. doi:
    1. Bruintjes M, van Helden EV, Braat AE, Dahan A, Scheffer GJ, van Laarhoven CMJH, et al. Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis. Br J Anaesth. 2017;118(6):834–42. Epub 2017/06/03. doi:
    1. Boon M, Martini C, Hellinga M, Bevers R, Aarts L, Dahan A. Influence of variations in arterial PCO2 on surgical conditions during laparoscopic retroperitoneal surgery. Br J Anaesth. 2016;117:59–65. doi:
    1. Damle RN, Alavi K. Risk factors for 30-d readmission after colorectal surgery: a systematic review. J Surg Res. 2016;200:200–207. doi:
    1. Schmid M, Chiang HA, Sood A, Campbell L, Chun FK, Dalela D, et al. Causes of hospital readmissions after urologic cancer surgery. Urol Oncol. 2016;34:236.e1–11. doi:
    1. Wick EC, Shore AD, Hirose K, Ibrahim AM, Gearhart SL, Efron J, et al. Readmission rates and cost following colorectal surgery. Dis Colon Rectum. 2011;54:1475–1469. doi:
    1. Centers for Medicare and Medicaid Services (CMS). HHS. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2013 rates; hospitals' resident caps for graduate medical education payment purposes; quality reporting requirements for specific providers and for ambulatory surgical centers. final rule. Fed Regist. 2012;77:53257–53750.
    1. Damle RN, Cherng NB, Flahive JM, Davids JS, Maykel JA, Sturrock PR, et al. Clinical and financial impact of hospital readmissions after colorectal resection: predictors, outcomes, and costs. Dis Colon Rectum. 2014;57:1421–1429. doi:
    1. Fecso AB, Szasz P, Kerezov G, Grantcharov TP. The effect of technical performance on patient outcomes in surgery: a systematic review. Ann Surg. 2017;265:492–501. doi:
    1. Fanelli V, Morita Y, Cappello P, Ghazarian M, Sugumar B, Delsedime L, et al. Neuromuscular blocking agent cisatracurium attenuates lung injury by inhibition of nicotinic acetylcholine receptor-α1. Anesthesiology 2016;124:132–140. doi:

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren